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Abstract
Background—Caregivers of patients with neurodegenerative diseases are at heightened risk for 
serious health problems, but health differences between individual caregivers abound.
Aims—To determine whether atrophy in patient brains could be used to identify caregivers at 
heightened risk for health problems and which patient variables mediate this relationship.
Methods—In 162 patient-caregiver dyads, we assessed patient atrophy using structural MRI, 
caregiver health, and patient behavior and cognitive symptoms.
Results—Patient atrophy in the right insula and medial frontal gyrus was associated with worse 
caregiver health; this relationship was partially mediated by patient neuropsychiatric symptoms, 
and assessing atrophy in these regions improved predictions of poor caregiver health above and 
beyond patient behavioral symptoms.
Conclusions—This study shows the value of patients’ brain data in identifying caregivers at risk 
for becoming sick themselves.
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Introduction
Neurodegenerative diseases are progressive illnesses that have devastating effects on 
cognitive, emotional, and motor functioning. Because neurodegenerative diseases are more 
prevalent in late life [1], demographic shifts towards an older population mean that 
caregiving is becoming an increasingly common concern for many families. Caring for a 
loved one with a neurodegenerative disease can be a highly meaningful part of family life; 
however, it can have deleterious impacts on caregivers’ health. Caregivers of individuals 
with dementia not only have dramatically higher rates of mental health problems (e.g., 
depression, anxiety) than non-caregiving adults [2], they also experience greater physical 
health problems and mortality risks than caregivers of individuals with other illnesses (e.g., 
cancer, stroke, and chronic disability [3]). Importantly, there is considerable variability in 
these adverse health effects between individual caregivers [4]. Thus, there is a pressing need 
to find reliable markers that predict which caregivers are at maximal risk for illness.
An emerging consensus is that behavioral symptoms (e.g., apathy and aggression) in people 
with dementia play a major role in accounting for adverse caregiver outcomes, even more so 
than cognitive or functional symptoms [5, 6]. Different neurodegenerative diseases target 
different large-scale brain networks [7], and thus afflicted individuals can present with quite 
different symptom profiles [8]. For example, Alzheimer’s disease (AD) typically targets the 
default mode network, which is anchored in the posterior parietal cortex [7, 9]. Individuals 
with AD primarily exhibit cognitive symptoms, such as problems with memory and spatial 
cognition. In contrast, behavioral-variant frontotemporal dementia (bvFTD) targets the 
salience network, which is anchored in the right insula [7, 9]. Individuals with bvFTD 
primarily exhibit behavioral symptoms in the realm of socioemotional functioning, such as 
apathy and loss of empathy. Consistent with the importance of behavioral symptoms, results 
indicate that caregivers of individuals with bvFTD may fare worse than caregivers of 
individuals with AD [10–12].
Attempts to identify behavioral symptoms in patients with neurodegenerative disease that 
are linked with adverse caregiver health outcomes have been hampered by lack of agreement 
as to which behaviors to measure and how best to measure them [6]. Thus, some researchers 
have focused on psychiatric behaviors (e.g., hallucinations and delusions) measured via 
clinician-rated caregiver interviews (e.g., Neuropsychiatric Inventory [NPI] [13]), while 
others have focused on emotional behaviors (e.g., reduced visual attention to disgusting 
films, extraneous negative emotions in response to films, and reduced empathic accuracy 
[14–16]) measured using well-controlled laboratory procedures. Examining the “patient 
behavior to caregiver health” pathway, whether by caregiver interviews or laboratory 
assessments, has been fruitful in understanding individual differences in adverse caregiver 
health outcomes [14, 17]. However, both approaches have limitations. For example, 
caregiver reports can be biased [18] and laboratory assessments can be time-consuming and 
costly.
There can be little argument that neurodegeneration plays the primary causal role in 
producing behavioral symptoms in patients [8]. Moreover, measurable signs of 
neurodegeneration may appear well before observable changes in behavior occur [19]. 
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Structural neuroimaging is increasingly being used as a routine part of patient assessment, 
thus providing a basis for characterizing patterns of neurodegeneration in individual patients. 
With such data being so readily available, there is a compelling case for evaluating the 
“patient brain to caregiver health” pathway for understanding individual differences in 
caregiver vulnerability to declines in health. Research evaluating this pathway have been 
quite rare (e.g., studies linking patient neurodegeneration or traumatic brain injury with 
caregiver burden [20, 21]). To our knowledge there have been no prior studies comparing the 
“patient brain to caregiver health” pathway with the “patient behavior to caregiver health” 
pathway. Comparing these pathways will inform researchers and clinicians about which 
patient measures may be more suitable to predict health outcomes in caregivers. If certain 
patient measures predict caregiver health outcomes, patient data may be further utilized to 
identify caregivers who may require additional support and assistance.
The present study examined whether patient neurodegeneration could be used to predict 
adverse health outcomes in their caregivers. We also included healthy controls (HCs) and 
their partners to provide a neurologically healthy reference group for assessing 
neurodegeneration in relationship to caregiver health. Caregiver and partner 
psychopathology and global health (i.e., mental and physical health) were assessed with two 
commonly used self-report symptom inventories. Neurodegeneration was quantified using 
whole-brain voxel-based morphometry (VBM) because we wanted to detect brain regions 
associated with both caregiver health measures. Thus, we did not employ region-of-interest 
analyses in order not to limit the scope of our examination. Additionally, for group level 
analyses, this whole-brain approach has shown greater accuracy than region-of-interest 
analyses in neurodegenerative disease [22]. Our primary hypothesis concerning the “patient 
brain to caregiver health” pathway was that neurodegeneration in areas thought to support 
socioemotional behavior (e.g., the insula and anterior cingulate cortex [23]) would be 
associated with worse caregiver health. Consistent with the literature [6, 14], we 
hypothesized that the relationship between neurodegeneration in patients and health in 
caregivers would be mediated by patient behavioral symptoms, but not by patient cognitive 
functioning. Finally, to begin to evaluate the relative value of the “patient brain to caregiver 
health” and “patient behavior to caregiver health” pathways, we conducted a set of 
exploratory analyses comparing the predictive power of the two pathways.
Subjects and Methods
Participants
The sample included 139 patients with different neurodegenerative diseases and 23 HCs who 
were evaluated through the Memory and Aging Center at the University of California, San 
Francisco (UCSF). UCSF research participants who received diagnostic screening and who 
had reliable informants were identified, and their caregivers or study partners were given the 
option to participate in an additional study at the University of California, Berkeley (UCB). 
Caregivers of patients (mostly spouses; see below) and partners of HCs were evaluated at the 
UCB. All participants or their caregivers, when appropriate (e.g., when patients could not 
consent for themselves or when caregivers were providing consent for their own 
Hua et al. Page 3
Dement Geriatr Cogn Disord. Author manuscript; available in PMC 2019 June 14.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
participation), provided consent at each site for projects approved by their respective 
institutional review boards.
The sample included patients with AD (n = 35), three subtypes of FTD (bvFTD [n = 32], 
semantic-variant primary progressive aphasia [n = 23], and nonfluent-variant primary 
progressive aphasia [n = 15]), corticobasal syndrome (CBS; n = 17), and progressive 
supranuclear palsy (PSP; n = 17), as well as neurologically healthy controls (HCs; n = 23). 
CBS and PSP are predominantly characterized by changes to motor functioning [24, 25]; 
these groups were included to increase the neuroanatomical and symptom heterogeneity of 
the patient sample. Patients’ diagnoses were provided by neurologists based on consensus 
research criteria [24–28].
Experimental Design
Patients were referred to UCSF through self-referral, clinician referral, or referral through 
Alzheimer’s Disease Research Centers. HCs were volunteer participants who were recruited 
from the community. The patients underwent detailed clinical interviews, neurological 
examination, functional assessment, neuropsychological evaluation, and structural magnetic 
resonance imaging (MRI) at UCSF. The HCs underwent identical neurological and cognitive 
assessments and were screened to ensure that they had no history of neurological, 
psychiatric, or cognitive disorders; only HCs who passed this screening were eligible study 
participants.
At UCB, the caregivers of patients and partners of HCs completed questionnaires about their 
demographics and their mental and physical health. In all, 83% of the caregivers and 
partners were spouses of the patients and HCs (see Table 1 for more details).
In our cross-sectional observational study, we conceptualized patient neurodegeneration as 
the independent variable, caregiver health as the dependent variable, and patient behavioral 
symptoms or cognitive functioning as potential mediators for the relationship between 
patient neurodegeneration and caregiver health.
In order to maximize statistical power, we included all dyads (n = 162) with available MRI 
and caregiver/partner health data. Given an α value of 0.005, power of 0.80, and medium 
effect size of F2 = 0.15 for a linear regression, we computed a suggested sample size of 163. 
We selected α = 0.005 to match the statistical threshold in our neuroimaging analyses. Thus, 
our sample size was adequate to detect a relationship between patient neurodegeneration and 
caregiver health.
Measures
Cognitive Functioning—Cognitive functioning was assessed in patients and HCs by a 
neuropsychologist using the Mini-Mental State Examination (MMSE [29]). MMSE scores 
range from 0 to 30, with lower scores indicating greater impairment in cognitive functioning.
Disease Severity—Disease severity was assessed in patients and HCs by a clinician using 
the Clinical Dementia Rating (CDR [30]). The CDR Total (scores range from 0 to 3) and 
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Sum of Boxes (CDR-Box) scores were computed for each participant (scores range from 0 
to 18). On both CDR measures, higher scores indicate greater functional impairment.
Behavioral Symptoms—Behavioral symptoms were assessed in patients and HCs using 
the NPI [13]. The NPI assesses psychopathology in neurodegenerative diseases to evaluate 
12 common neuropsychiatric symptoms: (1) delusions, (2) hallucinations, (3) agitation, (4) 
dysphoria, (5) anxiety, (6) apathy, (7) irritability, (8) euphoria, (9) disinhibition, (10) 
aberrant motor behavior, (11) night-time behavior disturbances, and (12) appetite and eating 
abnormalities. Clinicians administered the NPI to the patients’ caregivers and rated the 
severity and frequency of each neuropsychiatric symptom. A total score for all 
neuropsychiatric symptoms was calculated as an index of patient behavioral symptoms. Of 
the 139 caregivers, 135 completed this measure. Three out of 23 partners of HCs completed 
this measure; because of this small number, partner data for HCs were not included.
Psychopathology—Psychopathological symptoms were assessed in caregivers and 
partners using the Symptom Checklist 90-Revised (SCL-90-R [31]). The SCL-90-R is a 90-
item questionnaire that assesses 9 domains of psychopathology: (1) somatization, (2) 
obsessive-compulsive disorder, (3) interpersonal sensitivity, (4) depression, (5) anxiety, (6) 
hostility, (7) phobic anxiety, (8) paranoid ideation, and (9) psychoticism in the past week. 
For each item, the caregivers rated themselves on a 5-point scale from 0 (none) to 4 
(extreme). For the present study, we used the average score for all 90 items as a measure of 
psychopathology; higher scores indicate greater severity of psychopathological symptoms. 
The caregivers and partners from all 162 dyads completed this measure.
Global Health—Global health was assessed in caregivers and partners using the Medical 
Outcomes Study 36-Item Short Form Health Survey (SF-36 [32]). The SF-36 evaluates 8 
areas of mental and physical health in the past month: (1) physical functioning, (2) role 
limitations due to physical health problems, (3) role limitations due to emotional problems, 
(4) energy and fatigue, (5) emotional well-being, (6) social functioning, (7) pain, and (8) 
general health. Subscale scores were calculated by summing their items, and an SF-36 
composite score was computed by averaging the scores for all 8 subscales; higher scores 
indicate greater global health. The caregivers and partners from all 162 dyads completed this 
measure.
Neuroimaging—The patients and HCs underwent 1.5-T, 3-T, or 4-T research-quality 
structural MRI at UCSF. Structural neuroimaging analyses utilizing images collected across 
different modes of hardware have been shown to have robust effects [33] and are thus 
unlikely to cause artifacts with appropriate covariates. MR images of HCs were acquired 
within 12 months of their spouses having completed the questionnaires, and MR images of 
patients were included within 3 months of the caregivers having completed the 
questionnaires. The MR images were visually inspected for movement artifacts and poor 
scan quality. In total, 162 MR images were included in the neuroimaging analyses (139 of 
patients and 23 of HCs). See the Appendix for acquisition and preprocessing details.
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Analytic Plan
To examine the relationship between neurodegeneration in patients and health in caregivers 
(n = 162), we conducted two separate whole-brain VBM analyses: one predicting caregiver/
partner psychopathology and the other predicting caregiver/partner global health. For each 
analysis, we included caregiver/partner age, caregiver/partner sex (0 = male, 1 = female), 
patient diagnosis (HC = 0, patient = 1), patient disease severity, patient cognitive 
functioning, patient total intracranial volume, and two dummy-coded variables for MRI 
scanner field strength as covariates. The images were overlaid with MRIcron (http://
people.cas.sc.edu/rorden/mricron/index.html) on an MNI (Montreal Neurological Institute) 
average brain based on the gray and white matter templates used for preprocessing. See the 
Appendix for more details.
Because we were linking distal variables (neurodegeneration in one person and health in 
another) and were utilizing a whole-brain approach with conservative covariates, results for 
VBM were considered significant at p < 0.005 (uncorrected) to allow for visualization of 
spatial overlap within brain areas related to worse caregiver health outcomes from both 
measures (SCL-90-R and SF-36). The convergence of the two maps, defined as voxels 
contained in both maps at this threshold, allowed us to compute a specific and single index 
of brain volume associated with worse caregiver health by extracting and combining gray 
matter volumes from these regions. We used this single index to reflect consistent and 
specific caregiver vulnerability from the patient brain in mediation analyses and comparison 
of predictive power analyses.
To examine what influences the relationship between patient neurodegeneration and 
caregiver health, we ran separate analyses to determine whether the relationships between 
neurodegeneration in patients and psychopathology and global health in caregivers were 
mediated by (a) behavioral symptoms or (b) cognitive functioning in patients. These four 
mediational analyses tested indirect effects using a bootstrap estimation approach with 5,000 
samples and used the same covariates as the VBM analyses described above, with two 
exceptions: (1) the diagnosis covariate was not included, because HCs were not included, 
and (2) cognitive functioning was not included as a covariate when it was tested as a 
mediator. Given that a subset of our sample was used for these analyses (n = 135) with 
stringent covariates, our use of two different caregiver health outcomes, and the empirical 
and theoretical considerations that patient behavioral symptoms and cognitive functioning 
would have separate effects on caregiver health, we conducted four separate mediational 
analyses instead of two multiple mediation analyses.
To evaluate the relative predictive power of the “patient brain to caregiver health” pathway to 
the “patient behavior to caregiver health” pathway, we compared how well patient brain and 
patient behavior measures predicted caregiver health by calculating changes in explained 
variance (R2) in linear regression models. The first type of model included the covariates 
used in the VBM analyses described above (with the exception of diagnosis) and patient 
behavioral symptoms as predictors. In the second type of model, we entered the combined 
patient brain volumes from regions that were associated with worse caregiver health as an 
additional predictor.
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Results
Neural Correlates of Poor Caregiver Health
Psychopathological Symptoms—Whole-brain VBM analysis revealed multiple 
regions in which smaller volume in patients and HCs was associated with greater severity of 
psychopathological symptoms in caregivers and partners (p < 0.005, uncorrected). These 
included several medial frontal, prefrontal, cingulate, insular, temporal, and parietal regions. 
Online supplementary Figure S1 (for all online suppl. material, see www.karger.com/doi/
10.1159/000495345) displays the statistical maps. For a complete list of these regions, see 
online supplementary Table S1 for T-score and significance levels.
Global Health—Whole-brain VBM analysis revealed multiple regions in which smaller 
volume in patients and HCs was associated with worse global health in caregivers and 
partners (p < 0.005, uncorrected). These included multiple medial frontal, anterior temporal, 
insular, and ventrostriatal regions. Online supplementary Figure S2 displays the statistical 
maps. For a complete list of these regions, see online supplementary Table S2 for T-score 
and significance levels.
Consistent Neural Correlates of Worse Caregiver Health
The two T-score maps overlapped in two areas: the right ventral anterior insula (rvAI) and 
the superior medial frontal gyrus (smFG). Figure 1 displays areas of overlap. To ensure that 
these results were not driven by differences between patients and HCs or between 
individuals with FTD (where frontal and insular damage is common) and other patient 
groups, we conducted follow-up analyses.
Our first follow-up analysis (controlling for the same covariates) excluded HCs (n = 23). In 
this smaller sample (n = 123), the three T-score maps overlapped in the same two regions 
(rvAI and smFG; p < 0.005, uncorrected). Thus, including HCs did not change the 
relationship between patient neurodegeneration and caregiver health. See online 
supplementary Table S3 for T-score and significance levels and online supplementary Figure 
S3 for statistical maps.
Our second follow-up analysis (controlling for the same covariates) excluded individuals 
with FTD (n = 70; 32 with bvFTD, 15 with nonfluent-variant primary progressive aphasia, 
and 23 with semantic-variant primary progressive aphasia). In this smaller sample (n = 92; 
35 with AD, 17 with CBS, 23 HCs, and 17 with PSP), the three T-score maps overlapped in 
the rvAI (p < 0.005, uncorrected). Thus, including individuals with FTD did not change the 
relationship between rvAI and caregiver health but was important for the relationship 
between smFG and caregiver health. See online supplementary Table S4 for T-score and 
significance levels and online supplementary Figure S4 for statistical maps.
Mediation by Patient Behavioral versus Cognitive Symptoms
Patient behavioral symptoms partially mediated the relationship between patient brain 
volumes in the rvAI and smFG and caregiver psychopathology (standardized indirect effect 
= −0.05, 95% CI [−0.13, −0.003], accounting for 19% of the total effect)1 (Fig. 2). Patient 
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behavioral symptoms did not mediate the relationship between patient brain volumes in the 
rvAI and smFG and caregiver global health (standardized indirect effect = 0.04, 95% CI 
[−0.005, 0.12]).2
Patient cognitive functioning did not mediate the relationship between patient brain volumes 
in the rvAI and smFG and caregiver psychopathology (standardized indirect effect = 0.01, 
95% CI [−0.002, 0.05]) or between patient brain volumes in the rvAI and smFG and 
caregiver global health (standardized indirect effect = −0.009, 95% CI [−0.05, 0.006]).
Evaluating Pathways: “Patient Brain to Caregiver Health” versus “Patient Behavior to 
Caregiver Health”
Compared to the model with the covariates and patient behavioral symptoms as predictors, 
the model that included patient brain volumes (from the rvAI and smFG) as a predictor 
significantly increased the explained variance of the model predicting caregiver 
psychopathology (F(1, 124) = 4.79, p = 0.03, R2change = 0.03). In this latter model, both 
patient brain volumes in the rvAI and smFG (t = −2.19, β = −0.19, p = 0.03) and patient 
neuropsychiatric behavior (t = 2.70, β = 0.26, p = 0.008) were significant predictors of 
caregiver psychopathology (Table 2).
Compared to the model with the covariates and patient behavioral symptoms as predictors, 
the model that included patient brain volumes (from the rvAI and smFG) as a predictor 
significantly increased the explained variance of the model predicting caregiver global health 
(F(1, 124) = 7.40, p = 0.007, R2change = 0.05). In this latter model, both patient brain 
volumes in the rvAI and smFG (t = 2.72, β = 0.24, p = 0.007) and patient neuropsychiatric 
behavior (t = −2.11, β = −0.21, p = 0.04) were significant predictors of caregiver global 
health (Table 2).
Discussion
The present study demonstrated the value of patient brain data in predicting caregiver health, 
supporting the viability of a “patient brain to caregiver health” pathway. Smaller volume in 
the rvAI and smFG in patients emerged as the most consistent predictor of greater severity 
of psychopathology and worse global health in caregivers. Importantly, the results remained 
stable with or without HCs or individuals with FTD. The mediational analyses revealed that 
patient behavioral symptoms (but not cognitive functioning) partially mediated the 
relationship between smaller volume in these two regions in patients and the severity of 
psychopathological symptoms in caregivers (but not global health). Lastly, we found that 
patient volumes in these two regions significantly increased the explained variance in 
caregiver health outcomes beyond that accounted for by patient behavioral symptoms.
1No specific set of behavioral symptoms (i.e., disinhibition, apathy, euphoria, etc.) individually mediated the relationship between 
patient gray matter volumes in the rvAI and smFG and caregiver psychopathology, suggesting that the overall degree of behavioral 
symptoms mediates this relationship.
2To address whether patient behavioral symptoms specifically mediate the relationship between patient neurodegeneration and 
caregiver mental health, we computed a measure of caregiver mental health by averaging the following subscale scores on the SF-36: 
role limitations due to emotional problems, emotional well-being, and social functioning. Post hoc mediational analysis (using the 
same covariates as in the VBM analyses) revealed that patient behavioral symptoms mediated the relationship between patient gray 
matter volumes in the rvAI and smFG and caregiver mental health (derived from the SF-36; standardized indirect effect = 0.04, 95% 
CI [0.001, 0.12], accounting for 0.20 of the total effect).
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Specific Neural Predictors of Caregiver Health
The rvAI and the smFG are particularly important for emotional and social functioning. The 
insula is a core hub in the salience network; it integrates multiple streams of information, 
including speech-language, viscero-autonomic, and socioemotional processes [34], and it 
has been consistently found to support bodily awareness, representation of emotional states, 
and detection of relevant emotional stimuli [35, 36]. The ventral anterior insula (relative to 
dorsal regions) is particularly associated with socioemotional and autonomic processes [37]. 
Individuals with ventral anterior insula damage may lose access to key bodily and social 
cues important for emotional responding in social interactions. In our study, the rvAI 
remained the single consistent predictor of worse health outcomes in caregivers and study 
partners when excluding the FTD group, underscoring the importance of neurodegeneration 
in this region across diagnoses. Patients who become emotionally “disconnected” from 
bodily information, with all of the attendant benefits that would normally accrue for 
processes such as decision-making and responsiveness to social cues [38], are likely to 
behave in ways that are very difficult for caregivers. For example, lack of emotional 
responsivity in patients is particularly distressing for caregivers [39], likely fostering reduced 
relationship quality and declines in caregiver health.
The smFG supports behavioral response inhibition, an important executive control function 
that leads to regulation of behaviors [40]. Greater activation in the medial prefrontal cortex 
has also been linked to use of emotion regulation strategies, including reappraisal of a 
situation to view it in a different way and suppression of negative affect to reduce one’s 
response [41, 42]. Damage to superior medial frontal regions may lead to poor response 
inhibition, ineffective emotion regulation, and inappropriate social behaviors (e.g., 
aggression and impulsivity) in patients. These behaviors can confuse and frustrate 
caregivers, creating additional burden and distress which negatively impact their health.
Patient Behaviors as Mediators of Caregiver Health
The present research supports our study hypothesis that neurodegeneration in brain regions 
critical for patient socioemotional functioning may lead to adverse health outcomes in their 
caregivers. Because of our cross-sectional observational design, the findings from the 
present study show a strong association between patient neurodegeneration, patient 
behavioral symptoms, and caregiver health at the between-person level. Although other 
mediational pathways are certainly possible, it is compelling to posit that neurodegeneration 
causes behavioral changes in patients and that these behavioral changes add to the burden of 
caregiving, leading to declines in caregiver health.
We evaluated one behavioral mediator in patients assessed by clinician-rated 
neuropsychiatric symptoms and one assessed by neuropsychological testing (cognitive 
functioning). Behavioral symptoms partially mediated the relationship between patient 
neurodegeneration and caregiver psychopathology, but not for global health, suggesting the 
importance of patient neurodegeneration and behavior in influencing caregiver mental 
health. Finally, patient cognitive functioning did not mediate the relationship between patient 
neurodegeneration and caregiver health; this is consistent with previous findings concerning 
the greater impact of behavioral symptoms on caregiver health [6]. Future longitudinal 
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studies that measure patient neurodegeneration, patient behavioral symptoms, and caregiver 
health at multiple time points would allow for a full evaluation of these mediational 
pathways.
Value of the “Patient Brain to Caregiver Health” Pathway
Measuring brain volumes of the rvAI and smFG in patients significantly improved the 
prediction of both of our measures of caregiver health beyond patient behavioral symptoms 
and covariates. When considered together, brain volumes and behavioral symptoms were 
both significant independent predictors of caregiver psychopathology and caregiver global 
health. These findings suggest that the “patient brain to caregiver health” pathway can 
improve the prediction of adverse caregiver outcomes above and beyond the traditional 
“patient behavior to caregiver health” approach. Because different methodologies of 
measuring patient behavioral data have different advantages and disadvantages, we may 
never have the perfect behavioral measure. Our data suggest that including both MRI-
derived measures of brain neurodegeneration and caregiver reports of problematic patient 
behavioral ratings may be most useful for predicting individual differences in vulnerability 
to the adverse health effects of caregiving.
Strengths and Limitations
Strengths of the present study include: (a) sampling a variety of neurodegenerative diseases 
in a relatively large sample; (b) using well-validated measures of health symptoms; (c) using 
whole-brain VBM instead of region-of-interest analyses; and (d) examining the additive 
predictive power of patient brain data beyond patient behavior data to increase the accuracy 
of predicting individual caregivers’ heightened risk for poor health. Limitations included: (a) 
use of a cross-sectional study design that is limited in determining causality without multiple 
measures of patient neurodegeneration, patient behavior, and caregiver health; (b) use of 
self-report health measures rather than more objective measures; (c) the lack of patient 
comparison groups, so that we cannot address whether the found effects can be generalized 
to other forms of neurological illness, such as stroke; (c) lack of additional variables that 
also undermine caregiver health, such as perceived social support and financial burden; (d) 
having mostly spousal caregivers, so that the results may not generalize to other familial 
caregivers; and (e) the lack of ethnoracial diversity in the sample, which may limit the 
results’ generalizability to non-European American patients and caregivers.
Conclusions
Our findings show the value of the “patient brain to caregiver health” approach, 
demonstrating that measuring patient behaviors and patient neurodegeneration improves 
predictions of poor mental and physical health in caregivers. Poor health in caregivers has 
enormous costs for caregivers and the patients in their care. Our recent research has shown 
that poor mental health in caregivers predicts shorter survival of patients, even when 
accounting for other key risk factors [43]. Thus, identifying predictors of poor health in 
caregivers is a critically important area for research and intervention that may extend the life 
of both the caregiver and the patient. When treatment teams encounter patients with high 
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levels of neurodegeneration in specific regions, they may want to give particular attention to 
monitoring and treating health problems in their caregivers.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Appendix: Neuroimaging Acquisition and Preprocessing Details
Ten structural MR images (6%) were acquired on a 1.5-T Siemens Magnetom VISION 
system (Siemens, Iselin, NJ, USA) at the San Francisco Veterans Administration Hospital, 
equipped with a standard quadrature head coil, using a magnetization-prepared rapid 
gradient-echo (MPRAGE) sequence (164 coronal slices; slice thickness, 1.5 mm; field of 
view [FOV], 256 × 256 mm; matrix, 256 × 256; voxel size, 1.0 × 1.5 × 1.0 mm; repetition 
time [TR], 10 ms; echo time [TE], 4 ms; flip angle, 15°).
Forty MR images (25%) were acquired on a 4-T Bruker MedSpec system at the San 
Francisco Veterans Administration Hospital with an 8-channel head coil controlled by a 
Siemens Trio console, using an MPRAGE sequence (192 sagittal slices; slice thickness, 1 
mm; FOV, 256 × 224 mm; matrix, 256 × 224; voxel size, 1.0 × 1.0 × 1.0 mm; TR, 2,840 ms; 
TE, 3 ms; flip angle, 7°).
112 MR images (69%) were acquired on a 3.0-T Siemens TIM Trio scanner equipped with a 
12-channel head coil located at the UCSF Neuroscience Imaging Center using volumetric 
MPRAGE (160 sagittal slices; slice thickness, 1.0 mm; FOV, 256 × 230 mm; matrix, 256 × 
230; voxel size, 1.0 × 1.0 × 1.0 mm; TR, 2,300 ms; TE, 2.98 ms; flip angle, 9°).
For preprocessing, statistical parametric mapping version 12 default parameters were used 
with the light clean-up procedure in the morphological filtering step (http://
www.fil.ion.ucl.ac.uk/spm/software/spm12/). Structural T1 images were corrected for bias 
field, segmented into gray matter, white matter, and cerebrospinal fluid, and spatially 
normalized into MNI space [44]. Default tissue probability priors (voxel size, 2.0 × 2.0 × 2.0 
mm) of the International Consortium for Brain Mapping were used. Segmented images were 
visually inspected for adequate gray matter segmentation. These images were then smoothed 
with an 8-mm full-width-at-half-maximum gaussian kernel filter.
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Fig. 1. 
Consistent neural correlates of worse caregiver health. T-score maps of brain areas for which 
a smaller volume in patient and healthy control brains is associated with greater severity of 
caregiver psychopathological symptoms and worse caregiver global health (p < 0.005, 
uncorrected). The T-score maps overlap in the right ventral anterior insula and in the 
superior medial frontal gyrus. The results for all analyses are overlaid on an MNI template 
brain.
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Fig. 2. 
Behavioral symptoms as a mediator. Regression coefficients and standard error (SE) for the 
relationship between patient brain volumes (right ventral anterior insula and superior medial 
frontal gyrus) and caregiver psychopathology as mediated by patient behavioral symptoms 
on the Neuropsychiatric Inventory. * p < 0.05, ** p < 0.01.
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Table 1.
Means and standard deviations (in parentheses) for participant characteristics of caregivers and patients with 
neurodegenerative disease (or partners and controls) by diagnosis group, unless otherwise noted
Characteristic AD bvFTD CBS HCs nfvPPA PSP svPPA
Subjects, n 35 32 17 23 15 17 23
Caregiver/partner sex, % female 71 59 53 48 53 53 48
Caregiver/partner age, years 59.19 (8.35) 58.56 (14.39) 60.65 (11.09) 64.60 (10.66) 68.25 (15.73) 62.94 (8.00) 66.38 (14.80)
Caregiver/partner relationship, % spouses 86 81 71 83 93 88 83
Caregiver/partner ethnicity, n
 White/Caucasian/European American 31 24 12 22 14 16 23
 Latino/Chicano/Hispanic 0 1 1 0 0 0 0
 Black/Black American/Afro-Caribbean 0 0 1 0 0 0 0
 Asian/Asian American/South Asian 0 3 2 1 1 1 1
 Multi-racial/other 4 4 1 0 0 0 0
Patient Neuropsychiatric Inventory (NPI) 
score
21.03 (24.22) 41.45 (18.20) 22.40 (23.31) −(−) 15.14(13.20) 33.53 (19.30) 36.13 (19.12)
Patient Clinical Dementia Rating (CDR-
Box) score 3.99 (1.88) 6.84 (3.39) 3.82 (2.49) 0.00 (0.00) 2.20 (2.33) 5.82 (2.70) 3.95 (2.65)
Patient Mini-Mental State Examination 
(MMSE) score 22.23 (4.81) 23.31 (5.51) 22.18 (6.49) 29.60 (0.58) 23.40 (7.71) 26.70 (3.12) 23.36 (5.48)
Caregiver/partner Symptom Checklist 90 
(SCL-90) score 0.33 (0.23) 0.53 (0.36) 0.59 (0.74) 0.24 (0.20) 0.56 (0.44) 0.28 (0.18) 0.30 (0.33)
Caregiver/partner Short Form Health 
Survey (SF-36) score 78.97 (11.82) 75.51 (12.00) 73.88 (19.48) 85.20 (8.41) 72.10 (18.16) 77.39 (19.56) 80.81 (11.92)
NPI, patient neuropsychiatric (e.g., behavioral) symptoms; CDR-Box, dementia severity; MMSE, cognitive functioning; SCL-90, severity of 
psychopathological symptoms; SF-36, global health outcomes; AD, Alzheimer’s disease; bvFTD, behavioral-variant frontotemporal dementia; 
CBS, corticobasal syndrome; HCs, healthy controls; nfvPPA, nonfluent-variant primary progressive aphasia; PSP, progressive supranuclear palsy; 
svPPA, semantic-variant primary progressive aphasia.
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Table 2.
Evaluating pathways: “patient brain to caregiver health” versus “patient behavior to caregiver health”
R2 R2 adj R2 change df RSS RSSchange F-statistic p value
Dependent variable: caregiver psychopathology (SCL-90)
Model 1: behavior only 0.16 0.10 – 125 17.15 – 2.93 0.005
Model 2: behavior and brain 0.19 0.13 – 124 16.51 – 3.22 0.001
Model Δ – – 0.03 – – −0.64 4.79 0.030
Dependent variable: caregiver global health (SF-36)
Model 1: behavior only 0.11 0.05 – 125 13.72 – 1.95 0.059
Model 2: behavior and brain 0.16 0.10 – 124 13.38 – 2.64 0.008
Model Δ – – 0.05 – – −0.34 7.40 0.007
When patient brain volumes are added as predictors to the linear regression models predicting poor caregiver health, the explained variance is 
increased compared to when just patient behavioral symptoms and covariates are entered as predictors. “Behavior only” model predictors: patient 
behavioral symptoms (NPI) + caregiver age + caregiver sex + patient diagnosis + patient dementia severity + patient cognitive functioning + patient 
total intracranial volume + scanner field strength. “Behavior and brain” model predictors: (same as above) + patient brain volumes extracted from 
the right ventral anterior insula and superior medial frontal gyrus. RSS, residual sum of squares.
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